The patent protects Orthocell’s intellectual property for the preparation of bioscaffolds and tendon stem cells to treat rotator cuff tears. The intellectual property further protects Orthocell’s novel tendon regeneration technology, known as autologous tenocyte implantation.
More articles on devices:
FDA clears Life Spine’s expandable lateral interbody system
SpineGuard revenue drops 6% in 2014 so far: 10 key concepts
SI-BONE receives 13th patent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
